Tag
- Lonza acquires Roche US biologics facility for $1.2 billion 2024-10-08
- Lonza acquires biologics plant from Roche for $1.2 billion 2024-03-25
- Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug... 2023-12-06
- Aβ monoclonal antibody is broken again, Alzheimer's disease... 2022-11-18
- Roche to Introduce ATR Inhibitor RP-3500 for $1.2 Billion 2022-06-02
- Roche's Next-generation C5 Complement Inhibitor Crovalimab S... 2022-05-24
- Roche's TIGIT Monoclonal Antibody Collapses Again, And A Lar... 2022-05-19
- Roche's Q1 Performance Increases by 10%, And Total Revenue f... 2022-04-26
- Roche's Potential 'First-in-class' Bispecific Therapy Wins E... 2022-04-24
- Novartis has the most new drugs approved, and Roche's new dr... 2021-08-31
Market Analysis
- BDO Market Conditions Remain Weak, Pending Further Observations Feb-07,2026
- This Week's Isopropanol Market Prices First Increased Then Decreased (2.2-2.6) in China Feb-07,2026
- Ethanol Market Remains at High Levels with Consolidation Feb-07,2026
- Negative Factors Weighing Down, Palm Oil Prices Weak and Declining Feb-07,2026
- This Week's Activated Carbon Prices Rose (2.2-2.6) in China Feb-07,2026